1.41
2.08%
-0.03
Dopo l'orario di chiusura:
1.41
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals announces private placement sale - Investing.com
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com UK
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - StockTitan
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - StockTitan
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements - TipRanks
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors UK
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors UK
60 Degrees Pharmaceuticals Inc’s Mixed Bag: Down -39.50% in 6 Months, Down -7.00% in 30 Days - The InvestChronicle
Market Resilience: 60 Degrees Pharmaceuticals Inc (SXTP) Finishes Strong at 1.58, Up 1.28 - The Dwinnex
60 Degrees Pharmaceuticals Inc (SXTP)’s stock price range in the last year - US Post News
Q3 2024 EPS Estimates for 60 Degrees Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Rating Reaffirmed by HC Wainwright - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Issues Quarterly Earnings Results - Defense World
Financial Contrast: 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - citybiz
Thinking about buying stock in Nio Inc, 60 Degrees Pharmaceutica - GuruFocus.com
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
60 Degrees Pharmaceuticals reports doubled Q2 revenue - Investing.com India
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Canada
SXTP60 Degrees Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - ForexTV.com
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com UK
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - GlobeNewswire
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - Yahoo Finance
60 Degrees Pharmaceuticals Inc (SXTP) is looking forward to a strong quarter - SETE News
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Insider Monkey
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now? - Yahoo Finance
60 Degrees Pharmaceuticals Inc (SXTP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 29% Today? - InvestorPlace
Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines
Upcoming Stock Splits This Week (August 12 to August 16) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
A stock that deserves closer examination: 60 Degrees Pharmaceuticals Inc (SXTP) - US Post News
Bitcoin Miner Marathon to Sell Notes to Buy Cryptocurrency - Head Topics
Ratio Revelations: 60 Degrees Pharmaceuticals Inc (SXTP)’s Financial Metrics in the Spotlight - The Dwinnex
60 Degrees Pharma Provides University of Kentucky with - GlobeNewswire
60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study - StockTitan
WallachBeth Capital Announce Closing Of 60 Degrees Pharmaceuticals IPO At $5.30 Per Unit - Quantisnow
WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering - Quantisnow
Does 60 Degrees Pharmaceuticals Inc (SXTP) offer a good opportunity for investors? - SETE News
Analyzing the Impact of Earnings Reports on 60 Degrees Pharmaceuticals Inc Inc. (SXTP) Price Performance - The InvestChronicle
ARRY’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Agape ATP Corp Inc. (ATPC) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
60 Degrees Pharmaceuticals announces reverse stock split By Investing.com - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):